Literature DB >> 34110738

An Updated Systematic Review of Human Papillomavirus Genotype Distribution by Cervical Disease Grade in Women Living With Human Immunodeficiency Virus Highlights Limited Findings From Latin America.

Brittney L Dickey, Anna E Coghill, Grant B Ellsworth1, Timothy J Wilkin1, Luisa L Villa, Anna R Giuliano.   

Abstract

ABSTRACT: Cervical cancer is 5 times more likely among women living with human immunodeficiency virus (WHIV), likely due to higher prevalence of human papillomavirus (HPV). Despite evidence of higher rates with multiple HPV genotypes in WHIV, there are no recommendations for triage by HPV genotyping specific to WHIV. In Latin America/Caribbean rates are high and vary significantly. To guide optimization of HPV-based cervical cancer screening among WHIV in Latin America/Caribbean, review of current literature was completed to assess HPV genotype distribution by cervical disease grade in WHIV in this region; and further expanded globally for comparison across regions.A systematic review of the literature from June 2016 to January 2020 revealed 15 studies reporting human papillomavirus (HPV) genotype distribution by cervical disease state (normal, low-grade disease, high-grade disease, and invasive cervical cancer) across different global regions.Across all studies, there were 6928 WHIV from 4 global regions, 3952 of whom were HPV-positive. Three studies from Latin America/Caribbean (LAC) countries were reviewed, with 1 providing enough detail to describe HPV genotypes by cervical disease grade and identified types 31 and 35 in high-grade cervical lesions. Of the studies included, 4 from Africa and Europe/North America each, and 1 from Asia included data that were able to be summarized.Latin America, a region which experiences high rates of HPV, human immunodeficiency virus (HIV), and cervical disease, had few published studies reporting HPV genotypes by cervical disease grade, with 1 reporting individual HPV genotype and specific cervical disease grade. Identifying HPV types associated with CIN2+ in WHIV in this region has the potential to improve screening and treatment for cervical cancer prevention and should be the focus of future research.
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34110738      PMCID: PMC8525704          DOI: 10.1097/OLQ.0000000000001412

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  23 in total

1.  Human papillomavirus types among women infected with HIV: a meta-analysis.

Authors:  Gary M Clifford; Maria Alice G Gonçalves; Silvia Franceschi
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

2.  Long-term cumulative detection of human papillomavirus among HIV seropositive women.

Authors:  L Stewart Massad; Xianhong Xie; Robert Burk; Marla J Keller; Howard Minkoff; Gypsyamber DʼSouza; D Heather Watts; Joel Palefsky; Mary Young; Alexandra M Levine; Mardge Cohen; Howard D Strickler
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

3.  Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.

Authors:  Luana L S Rodrigues; Mariza G Morgado; Vikrant V Sahasrabuddhe; Vanessa S De Paula; Nathália S Oliveira; Elena Chavez-Juan; Diane M Da Silva; W Martin Kast; Alcina F Nicol; José H Pilotto
Journal:  Gynecol Oncol       Date:  2018-08-04       Impact factor: 5.482

Review 4.  The changing face of HIV in Latin America and the Caribbean.

Authors:  Patricia J García; Angela Bayer; César P Cárcamo
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

5.  Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil.

Authors:  Brenda Evelin Barreto da Silva; Victor Santana Santos; Ingrid Emmily Reis Santos; Edilaine Dória Araújo; Melina Vieira Alves; Letícia Alves Dos Santos Silva; Marcus Vinicius de Aragão Batista; Lígia Mara Dolce de Lemos
Journal:  J Med Virol       Date:  2020-04-24       Impact factor: 2.327

Review 6.  Human papillomavirus, human immunodeficiency virus and immunosuppression.

Authors:  Lynette A Denny; Silvia Franceschi; Silvia de Sanjosé; Isabelle Heard; Anna Barbara Moscicki; Joel Palefsky
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

7.  A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

Authors:  Jessica L Castilho; José Eduardo Levi; Paula M Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Mônica Derrico; Valdiléa G Veloso; Beatriz Grinsztejn; Ruth K Friedman
Journal:  BMC Cancer       Date:  2015-06-23       Impact factor: 4.430

8.  Clustering patterns of human papillomavirus infections among HIV-positive women in Kenya.

Authors:  Salvatore Vaccarella; Hugo De Vuyst; Nelly R Mugo; Samah R Sakr; Martyn Plummer; Daniëlle A M Heideman; Silvia Franceschi; Michael Chung
Journal:  Infect Agent Cancer       Date:  2013-12-19       Impact factor: 2.965

Review 9.  Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.

Authors:  Gary M Clifford; Stephen Tully; Silvia Franceschi
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

10.  Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.

Authors:  G Orlando; S Bianchi; M M Fasolo; F Mazza; E R Frati; G Rizzardini; A Matteelli; N Zanchetta; A Amendola; E Tanzi
Journal:  J Prev Med Hyg       Date:  2017-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.